Publications

Books and Book Chapters:
  • Zhou Q,Sneed KB, & Zhou SF. Roadmap to success for pharmacy students in the US. In “Pharmacy for the Curious: Why Study Pharmacy?” Edited by Dr Kishor Vaidya, PhD, University of Canberra, Canberra, Australia.
  • Zhou SF. Pharmacokinetics of anticancer Materia Medica in humans. In “Evidence-based Anticancer Complementary and Alternative Medicine Vol 2: Materia Medica for Various Cancers” edited by WC Cho, Springer, 2012, pp353-395 (ISBN: 978-94-007-0525-8).
  • Zhou SF, Liu JP, Wei MQ,& Duan W. Role of multidrug resistance associated proteins in drug development. In “Multiple drug Resistance” edited by Khan A & Zarrilli R, Bentham Science Publishers, New York, 2012; pp3-35.
  • Nguyen TH, Cao S,Zhou SF,& MQ Wei.Chapter 17:Future developments in electroporation: Recombinant Clostridia as viable and targeted tumour therapeutics. In “Electroporation in Laboratory and Clinical Investigations” edited by Spugnini EP& Baldi A. Nova Science Publishers, New York, 2011; pp315-328.
  • Zhou SF, Liu JP,&Chan E. Chapter 9: Induction and inhibition of the human cytochrome P450 3A4 and implication in clinical drug monitoring. In Handbook ofDrug Targeting and Monitoring(Editors: Andreev B & Egorov V). Nova Science Publishers, Inc. New York, 2010, pp203-354.
  • Zhou SF. Toxicology, safety, and herb-drug interactions in cancer therapy. In “Supportive Cancer Care with Chinese Medicine” by WC Cho, Springer, 2010, pp 293-340.
  • Li P & Zhou SF. Herb-drug interactions and implications in drug monitoring. In Drug monitoring: developments, challenges, and applications (Editor: Frank Columbus). Nova Science Publishers, Inc. New York, 2009.
  • Gao YH & Zhou SF. Mechanisms for the antitumor effect of the refined polysaccharides extracted from Ganoderma lucidum in mice. In “Recent Progress In Medicinal Plants , Vol 17: Phytochemistry and Pharmacology III”(Editors: Singh VK, JN Govil, &Arunachalam C).  Studium Press LLC, Houston, Texas, USA. 2007.
  • Zhou SF. Hepatoprotective activity and underlying mechanisms of Ganoderma lucidum.In “Recent Progress In Medicinal Plants , Vol 17: Phytochemistry and Pharmacology III”(Editors: Singh VK, JN Govil, &Arunachalam C).  Studium Press LLC, Houston, Texas, USA. 2007.
  • Low LS, Wong WH, Duan W, Zhou SF,Chou E,& Zhu YZ. The Prophylactic effects of Chinese herbal extract,‘Braintone@” on stroked Wistar rats. In “Natural Products: Essential Resource for Human Survival” (Editors: Zhu YZ, Tan BKH & Bay BH). World Scientific Publisher. Singapore, 2007. pp365-374.
  • Zhou SF, Gao YH, Dai XH, Ye JX & Huang M. Herbal development and clinical trials: challenges and strategies.In “Natural Products: Essential Resource for Human Survival” (Editors: Zhu YZ, Tan BKH, & Bay BH). World Scientific Publisher. Singapore, 2007.
  • Zhou SF, Kestell P & Paxton JW. Prediction of in vivo clearance and drug interactions for 5,6-dimethylxanthenone-4-acetic acid (DMXAA), an anti-cancer drug primarily eliminated by glucuronidation. In: Eds. Pandalai SG, Recent research developments in drug metabolism and disposition (ISBN: 81-7895-038-3). Transworld Research Network Publisher, Trivandrum, India, 2004.
  • Zhou SF. Separation and detection methods for covalent drug-protein adducts, in Interactions in Biological Systems by Miksik I & Deyl Z, Elsevier, Amsterdam, Netherlands, pp63-90, 2003.
  • Zhou SF. Studies on the mechanisms involved in the pharmacokinetic DMXAA-drug interactions. PhD Thesis, 2001, the University of Auckland, Auckland, New Zealand.
  • Gao YH, Zhou SF,& Buchanan P.Ganoderma: Systematics, Biochemistry, Pharmacology and Therapeutics. Proceedings of International Symposium on Ganoderma Science, April 27-29, 2001, Auckland, New Zealand.
Conference Abstracts (Peer-reviewed & Published in Proceedings or Journals):
  • Pan SY, & Zhou SF. Pharmacodynamics of schisandrin B- and Fructus Schisandrae oil-induced hypertriglyceridemia, hepatomegaly, and liver damage. The 17th World Congress of Basic and Clinical Pharmacology (WCP2014), July 13-18, 2014, CTICC, Cape Town, South Africa.
  • Pan SY, & Zhou SF. Dietary peel from Fructus Schisandra supplementation reduces serum/hepatic lipid and hepatic glucose levels in mice fed a normal or high cholesterol/bile salt diet. The 17th World Congress of Basic and Clinical Pharmacology (WCP2014), July 13-18, 2014, CTICC, Cape Town, South Africa.
  • Pan SY, & Zhou SF. Effects of fenofibrate co-administrated with Fructus Schisandrae peel extract on lipid and glucose metabolism in normal and high cholesterol/bile salt diet-fed mice, with attention to hepatotoxicity.The 17th World Congress of Basic and Clinical Pharmacology (WCP2014), July 13-18, 2014, CTICC, Cape Town, South Africa.
  • Pan SY, & Zhou SF. Effects of Fructus Schisandrae extract supplement on serum/hepatic lipids and glucose in normal diet- and hypercholesterolemic diet-fed mice.The 17th World Congress of Basic and Clinical Pharmacology (WCP2014), July 13-18, 2014, CTICC, Cape Town, South Africa.
  • Sun JZ, Heller I, & Zhou SF. Molecular mechanisms for the anti-cancer effects of Ai Kang (癌康),a herbal formula.First Symposium on Chinese Medicine: When the West meet with East. June 19, 2014, University of South Florida, Tampa, FL33612.
  • Wang JY & Zhou SF. Epigenetic mechanisms for the therapeutic effects of acupuncture for hypertension. First Symposium on Chinese Medicine: When the West meet with East. June 19, 2014, University of South Florida, Tampa, FL33612.
  • Yu Y & Zhou SF. Effects of herbal medicines on ADME genes: The good and the bad.First Symposium on Chinese Medicine: When the West meet with East. June 19, 2014, University of South Florida, Tampa, FL33612.
  • Zhang LF, Cao CH, & Zhou SF. Effect of the combination of caffeine and melatonin on Aβ40/42 levels in N2a/APP cells. First Symposium on Chinese Medicine: When the West meet with East. June 19, 2014, University of South Florida, Tampa, FL33612.
  • Zhang Y, Pan SY, & Zhou SF. Mechanisms for the hepatotoxicity of Wuweizi (Schisandrae fructus), a commonly used herbal medicine for liver protection.First Symposium on Chinese Medicine: When the West meet with East. June 19, 2014, University of South Florida, Tampa, FL33612.
  • Zhou ZW & Zhou SF. The molecular interactome of plumbagin: a bioinformatic, proteomic, and functional study with a focus on apoptosis and autophagy-associated pathways in human prostate cancer cells. First Symposium on Chinese Medicine: When the West meet with East. June 19, 2014, University of South Florida, Tampa, FL33612.
  • Sun JZ, & Zhou SF. The American Association for Cancer Research Annual Meeting 2014, April 5– 9, 2014, San Diego, CA.
  • Cheng F & Zhou SF.Sex difference in the brain of patients with Down’s syndrome.24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Cheng J, Niu NK, Cao CH, & Zhou SF. Polymer micelle-encapsulated mutant Aβ fragment as Alzheimer’s disease vaccine targeting oligomeric Aβ. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Chow K, Liang J, & Zhou SF. Prediction of microRNAs that may regulate human cytochrome P450 genes. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Ding YH, Yuan CX, & Zhou SF. Role of the aurora kinase A inhibitor, alisertib, in the treatment of ovarian cancer. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Durlacher C & Zhou SF. Targeting Na+/K+atpase in the treatment of prostate cancer. 24nd Annual USF Health Research Day, February 21, 2014, USF, Tampa, Florida.
  • Heller IE, Yang L, Li MH, Raplee I, Guzman S, Pasciak JP, Sneed KB, He L, Zhou SF, & Sun JZ. Repositioning of the FDA-approved anti-cancer tyrosine kinase inhibitors to treat metabolic diseases. 24nd Annual USF Health Research Day, February 21, 2014, USF, Tampa, Florida.
  • Hu CB & Zhou SF. Targeting epithelial-mesenchymal transition in the treatment of ovarian cancer. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Li H, Wang F, Zhou ZW, Yuan CX, & Zhou SF. Treatment of human colorectal cancer by Na+/K+ ATPase inhibitors. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Li JP, Zhou ZW, & Zhou SF. Inhibition of Mitotic Aurora A Kinase in the Treatment of Breast Cancer. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Li H, Wang JY, Ma CM, Wang JL, Zhou ZW, Lai XS, & Zhou SF. Brain microRNA profiling in spontaneously hypertensive rats. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Li M, Zhou ZW, & Zhou SF. Role of microRNA-21 in the immune response and programed cell death of human lung epithelial cells exposed to PM2.5 particulate matters. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Li MH & Zhou SF. MiR-299 Suppresses the growth of ovarian cancer cells through targeting the CA-125 (MUC16) gene. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Li Q & Zhou SF. Novel polymeric nanoparticles containing tanshinone-IIA from Chinese herbal medicine: Preparation, characterization, and antitumor activity. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Liang J, Yuan MD, Zhou ZW, He ZX, Chew H, & Zhou SF. Current therapeutic targets for type 2 diabetes mellitus (T2DM): A bioinformatic & molecular docking study. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Lin D, Wu Q, Borlonga CV, He ZX, Tan J, Zhou ZW, Cao CH, & Zhou SF. Telomerase alters the hippocampal response to acupuncture via modulation of the brain-derived neurotrophic factor (BDNF) signaling pathway in mice. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Luo RJ & Zhou SF. Metabonomic response to the treatment of tyrosine kinase inhibitors in human hepatocarcinoma cells. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Niu NK, Yin JJ, & Zhou SF. Synthesis and biological evaluation of novel targeted PEGylated liposomes conjugated with four anti-tubercular drugs & siRNA complexes in the treatment of TB. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Persaud-Sharma V, Yin JJ, Zhou ZW, Liang J, & Zhou SF. Chemical characterization and cytotoxicity of electronic cigarette refill cartridge fluid. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Thach C & Zhou SF.The anti-tumor drug 5,6-dimethyl-xanthenone-4-acetic acid (DMXAA) induces apoptosis via the nuclear orphan receptor Nur77-mediated pathway.24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Qin YR, Zhou ZW, & Zhou SF. In vitro immunotoxicity evaluation of graphene quantum dots. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Sun JZ, Yang L, Li MH, Heller IE, Raplee I, Guzman S, Pasciak JP, Prasad AK, Cheng F, Buchanan L, Roehm D, Finn L, Sneed KB, He L,& Zhou SF.Crizotinib induces tumor suppressor miR-146a and p21Waf1/Cip1 by alternative targeting non-TK target Akt-mTOR-Foxo axis. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Wang F, Li H, & Zhou SF. Plumbagin induces programed cell death in human pancreatic cancer cell lines. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Wang JY, Li H, Ma CM, Zhou ZW, Lai XS, & Zhou SF. Role of microRNAs in acupuncture treatment in hypertensive rats. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Wang Q, He ZX, Zhou ZW, Yang YX, & Zhou SF. 5,6-Dimethyl-xanthenone 4-acetic acid (DMXAA) induces apoptotic and autophagic cell death through suppression of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Wang QG, Zhou ZW, & Zhou SF. Mechanistic studies on sorafenib-induced cardiotoxicity. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Wang YY, Zhe H, Zhou ZW, Li XX, Li JP, & Zhou SF. CDDO-Me, an Nrf2 agonist, induces apoptosis and autophagy of esophageal squamous cell carcinoma by inhibiting Akt/mTOR and activating p38-MAPK. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Wang ZX, & Zhou SF. Bioinformatic prediction of the micrornas that regulate ABC transporter genes. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Yin JJ & Zhou SF. Development of a novel cyclodextrin-fullerene supramolecular complex for targeted siRNA delivery.24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Yin JJ & Zhou SF. Temporally controlled drug release, cholesterol scavenging and non-genomic response by multifunctional self-assembled cyclodextrin-based supramolecules. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Yuan CX, Ding YH, & Zhou SF. Targeting mitotic aurora a kinase in the treatment of gastric cancer. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Zhang LF, Cao CH, & Zhou SF. Effect of melatonin in combination with caffeine on β-amyloid production in N2a App cells. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Zhang Z, Cao CH, & Zhou SF. A novel, multi-component, multi-targeted “cocktail” from natural products for the treatment of Alzheimer’s disease. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Zhou ZW, Li XX, & Zhou SF. Induction of apoptosis and autophagy and suppression of epithelial-mesenchymal transition via Sirtuin 1-mediated pathway by plumbagin in human prostate cancer cells. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Zhu FQ, Zhou  ZW, Zhou SF, & Wen JB. Oxymatrine improves intestinal barrier function in hepatic cirrhosis by inhibiting activation of NF-kB p65. 24nd Annual USF Health Research Day, February 21, 2014, Marshall Student Center, University of South Florida, Tampa, Florida.
  • Zhou SF. How to go from 0 to 350 publications? Fall 2013 Interprofessional Faculty Development Workshop, December 16, 2013, University of South Florida, Tampa, FL 33612.
  • Zhou SF. Drug repositioning: Where we are and how far we can go, American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, November 9-14, 2013, San Antonio, TX.
  • Zhou SF. PK/PD modeling and systems pharmacology in drug discovery and development, American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, November 9-14, 2013, San Antonio, TX.
  • Zhou SF. Evidence-based application of herbal medicines, American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, November 9-14, 2013, San Antonio, TX.
  • Yin JJ & Zhou SF. Host-gust interaction mediated and ligand targeted nanoformulations for the delivery of therapeutics and their biomedical applications in the treatment of cancer. Symposium: Polymers for Drug Delivery. November 1, 2013, College of Pharmacy, University of South Florida, Tampa, FL.
  • Qin YR & Zhou SF. Graphene quantum dot-based theranostics for cancer detection and treatment. Symposium: Polymers for Drug Delivery. November 1, 2013, College of Pharmacy, University of South Florida, Tampa, FL.
  • Luo RJ & Zhou SF. Metabonomics study on human hepatocarcinoma cells treated with tyrosine kinase inhibitors. Office of Research and Scholarship Oktoberfest, College of Arts and Sciences, University of South Florida, Tampa, FL.
  • Zhou ZW & Zhou SF. Integrating metabolomics application and ingenuity pathway analysis to explore the response of non-small cell lung cancer cells to DMXAA and plumbagin. The 6th Annual NanoScience Technology Symposium NanoFlorida 2013, September 29-30, 2013, Gainesville, FL.
  • Yin JJ & Zhou SF. Estrogen anchored multifunctional micelles designed for site-specific delivery of doxorubicin prodrug in breast cancer therapy. The 6th Annual NanoScience Technology Symposium NanoFlorida 2013, September 29-30, 2013, Gainesville, FL.
  • Qin Y & Zhou SF. One-step facile ppreparation of graphene quantum dots for ovarian cancer detection. The 6th Annual NanoScience Technology Symposium NanoFlorida 2013, September 29-30, 2013, Gainesville, FL.
  • Li M & Zhou SF. Role of microRNAs in the damages of human respiratory epithelial cells exposed to air particulate matters. The 6th Annual NanoScience Technology Symposium NanoFlorida 2013, September 29-30, 2013, Gainesville, FL.
  • Zhou SF. Application of nanobiotechnology to deliver therapeutic drugs selectively to diseased sites with improved response and lowered toxicity. International Conference on Nanoscience & Technology, September 5-7, 2013, Beijing, China.
  • Persaud-Sharma V & Zhou SF. Characterization of particle size and chemical profiling of electronic cigarette refill cartridge fluid. 11th Raymond N. Castle Student Research Conference, April 20, 2013, USF, Tampa, FL 33612.
  • Sharma S, Yin JJ & Zhou SF. Preparation and biological evaluation of novel β-cyclodextrin based estrone conjugate drug complex in the treatment of estrogen receptor-positive breast cancer. 11th Raymond N. Castle Student Research Conference, April 20, 2013, USF, Tampa, FL 33612.
  • Yin JJ & Zhou SF. Synthesis and biological evaluation of a novel cancer treatment based on folic acid receptor-targeted, β-cyclodextrin-based drug complexes. The American Association for Cancer Research Annual Meeting 2013, April 6 - 10 2013, Walter E. Washington Convention Center, Washington D.C.
  • Jiazhi Sun, Yang L, Li M, Wang Z, Haynes A, Wang Q, Raplee I, Melchisedek J, Prasad A, Sneed KB, He L & Zhou SF. Indication switching of the FDA-approved anti-cancer tyrosine kinase inhibitors to treat metabolic diseases.The American Association for Cancer Research Annual Meeting 2013, April 6 - 10 2013, Walter E. Washington Convention Center, Washington D.C.
  • Zhou SF. Establishing genotype-phenotype relationships in cardiovascular pharmacogenetics. 15th South China International Congress on Cardiology, April 11-14, Guangzhou, China.
  • Li MH & Zhou SF. microR-561 exaggerates acetaminophen-induced hepatotoxicity through down-regulation of DAX-1. 2013 International Conference of RNA Nanotechnology and Therapeutics, April 2-5, Lexington, KY40506.
  • Qin YR & Zhou SF. siRNA therapy of breast cancer by targeted and traceable graphene quantum dot-based delivery system. 2013 International Conference of RNA Nanotechnology and Therapeutics, April 2-5, Lexington, KY40506.
  • Wang Q & Zhou SF. A new pRNA dimmer drug delivery system for tuberculosis therapy. 2013 International Conference of RNA Nanotechnology and Therapeutics, April 2-5, Lexington, KY40506.
  • Yin JJ & Zhou SF. Novel amphiphilic cyclodextrin-fullerene supramolecules for the site-specific delivery of siRNA. 2013 International Conference of RNA Nanotechnology and Therapeutics, April 2-5, Lexington, KY40506.
  • Zhou SF. Non-coding RNAs as new theranostic tools. 2013 International Conference of RNA Nanotechnology and Therapeutics, April 2-5, Lexington, KY40506.
  • Cates RS & Zhou SF. Polymeric nanoparticle-aptamer bioconjugates for cancer treatment. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Li M & Zhou SF. microR-561 exaggerates acetaminophen-induced hepatotoxicity through down-regulation of  DAX-1. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Li Q & Zhou SF. Novel polymeric nanoparticles containing tanshinone-IIA from Chinese herbal medicine: Preparation, characterization, and antitumor activity. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Li Y & Zhou SF. Anticancer effect and mechanism of plumbagin on human non–small-cell lung cancer cells. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Li Y, Yin JJ & Zhou SF. Effects of a novel nano-particle on human non–small-cell lung cancer cells. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Liang J, Bai G, Cao C, & Zhou SF. A novel, multi-component, multi-targeted “cocktail” from natural products for the treatment of Alzheimer’s disease. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Liang J, Guo Q, Xu H, & Zhou SF. Osteogenesis of goat bone marrow mesenchymal stem cells induced by transfection of BMP-2 and bFGF. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Liang J, Kang KF, Cheng F & Zhou SF. Beclin 1 and nuclear factor-κBp65 as potential biomarkers for hepatocellular carcinoma. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Luo R & Zhou SF. Metabonomics study on human hepatocarcinoma cells treated with tyrosine kinase inhibitors. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Persaud-Sharma V & Zhou SF. Cytotoxic effects of electronic cigarette refill cartridge fluid on human alveolar epithelial cells. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Q Wang & Zhou SF. A new nanoscaled targeted therapy for osseous tuberculosis. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Qin Y & Zhou SF. One-step fast and facile preparation of graphene quantum dots from graphite for bioimaging application. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Raplee I, Yang L, Li M, Zhou SF, & Sun J. Crizotinib induces autophagy and p21Waf1and arrests cell cycle in G2/M by alternative targeting non-TK targetAkt/mTOR pathway. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Sun J, Yang L, Li M, Prasad A, Wang Z, Haynes A, Wang Q, Raplee I, Melchisedek J, Sneed KB, He L & Zhou SF..Indication switching of the FDA-approved anti-cancer tyrosine kinase inhibitors (TKIs) to treat metabolic diseases.USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Wang Z, Liang J & Zhou SF. Bioinformatic prediction of the microRNAs that regulate ABC transporter genes. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Yin JJ & Zhou SF. Estrogen anchored multifunctional micelles designed for site-specific delivery of doxorubicin prodrug in breast cancer therapy. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Yin JJ & Zhou SF. Molecularly Self-assembled Fullerene and Amphiphilic Cationic Cyclodextrin Based Nanoparticles for siRNA Delivery. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Zhou SF. Teaching of pharmacogenetics for pharmacy students. USF Health College of Pharmacy 1st Education & Research Forum, March 27, 2013, Tampa, FL33612.
  • Baksh M, Trenozhnikova L, Albert  S, Seaton L, Patel A, Faza C, Whitaker  J, Mayer C, Roberts J, Pathak Y, Zhou SF, Calcul L and Azizan A. Antagonistic Activities of Extremophile Kazakhstan Extracts Against Drug-Resistant Hospital-Associated Pathogens. 23nd Annual USF Health Research Day, February 22, 2013, Tampa, Florida.
  • Cheng F & Zhou SF. Gene Networks implicated in acetaminophen-induced hepatotoxicity. 23nd Annual USF Health Research Day, February 22, 2013, Tampa, Florida.
  • Chew H, Liang J & Zhou SF. Interactome of the anticancer herbal drug plumbagin. 23nd Annual USF Health Research Day, February 22, 2013, Tampa, Florida.
  • Li MH & Zhou SF. MicroR-561 exaggerates acetaminophen-induced hepatotoxicity through down-regulation of DAX-1. 23nd Annual USF Health Research Day, February 22, 2013, Tampa, Florida.
  • Li Q & Zhou SF. Novel polymeric nanoparticles containing tanshinone-IIA from Chinese herbal medicine: Preparation, characterization, and antitumor activity. 23nd Annual USF Health Research Dayy, February 22, 2013, Tampa, Florida.
  • Li YC, Yin JJ & Zhou SF. Effects of a novel nano-particle on human non–small-cell lung cancer cells. 23nd Annual USF Health Research Day, February 22, 2013, Tampa, Florida.
  • Liang J, Kai KF & Zhou SF. Beclin 1 and nuclear factor-κBp65 as potential biomarkers for hepatocellular carcinoma. 23nd Annual USF Health Research Day, February 22, 2013, Tampa, Florida.
  • Lin D, Sun JZ & Zhou SF. Crizotinib induces autophage and p21Waf1 and arrests cell cycle in G2/M by alternative targeting non-TK target Akt/mTOR pathway cascade. 23nd Annual USF Health Research Day, February 22, 2013, Tampa, Florida.
  • Luo RJ & Zhou SF. Metabonomics study on human hepatocarcinoma cells treated with tyrosine kinase inhibitors. 23nd Annual USF Health Research Day, February 22, 2013, Tampa, Florida.
  • Sun JZ, & Zhou SF. Indication switching of the FDA-approved anti-cancer tyrosine kinase inhibitors to treat metabolic diseases. 23nd Annual USF Health Research Day, February 22, 2013, Tampa, Florida.
  • Vishwani P, Yin JJ & Zhou SF. Characterization of particle size and chemical profiling of electronic cigarette refill cartridge fluid. 23nd Annual USF Health Research Day, February 22, 2013, Tampa, Florida.
  • Wang Q & Zhou SF. A new nanoscaled targeted therapy for osseous tuberculosis. 23nd Annual USF Health Research Day, February 22, 2013, Tampa, Florida.
  • Wang ZX, Liang J & Zhou SF. Bioinformatic prediction of the microRNAs that regulate ABC transporter genes. 23nd Annual USF Health Research Day, February 22, 2013, Tampa, Florida.
  • Yin JJ & Zhou SF. Estrogen anchored multifunctional micelles designed for site-specific delivery of doxorubicin prodrug in breast cancer therapy. 23nd Annual USF Health Research Day, February 22, 2013, Tampa, Florida 33612 (Oral).
  • Sun JZ & Zhou SF. p53 & the Beyond Symposium, February 5, 2013, USF, Tampa, FL 33612.
  • Zhou SF. Application of nanotechnology to improve the pharmacokinetic and pharmacodynamic behaviors of existing drugs. NanoForum 2013: Nanotherapeutics and opportunities, January 24, 2013, Tampa, FL 33612.
  • Zhou SF& Cheng F. Developing CAMLS in China. Showcase of Global USF Health, October 18, 2012, University of South Florida, Tampa, Florida.
  • Baksh M, Trenozhnikova L, Seaton L, Patel A, Faza C, Whitaker J, Mayer C, Roberts J, Pathak Y, Zhou SF& Aziz A. Antagonistic activities of extremophile Kazakhstan extracts against drug-resistant hospital-associated pathogens. Showcase of Global USF Health, October 18, 2012, University of South Florida, Tampa, Florida.
  • Zhou SF& Cheng F. USF-Dekang project: New nanoformulated tobacco juice may reduce the harm of smoking. Showcase of Global USF Health, October 18, 2012, University of South Florida, Tampa, Florida.
  • Yin JJ, Zhang YD & Zhou SF. Synthesis and biological characterization of novel b-cyclodextrin based folic acid receptor targeting drug complex for cancer therapy. Showcase of Global USF Health, October 18, 2012, University of South Florida, Tampa, Florida.
  • Liang J, Chen XW & Zhou SF. Therapeutic effect of transplanting magnetically labeled bone marrow stromal stem cells in a rat liver injury model with 70%-hepatectomy. Showcase of Global USF Health, October 18, 2012, University of South Florida, Tampa, Florida.
  • Yin JJ, Zhang YD & Zhou SF. Preparation and biological assessment of novel β-cyclodextrin based estrone conjugate drug complex for the treatment of cancer. Showcase of Global USF Health, October 18, 2012, University of South Florida, Tampa, Florida.
  • Zhou SF, Cheng F & Rogers TM. China: A gold mine for partnership in healthcare education and research. Showcase of Global USF Health, October 18, 2012, University of South Florida, Tampa, Florida.
  • Liang J, Chen X & Zhou SF. Polymorphisms in folate pathway genes and response to methotrexate treatment in rheumatoid arthritis. Showcase of Global USF Health, October 18, 2012, University of South Florida, Tampa, Florida.
  • Zhou SF& Cheng F. Nanchang University (NCU), Nanchang, China as our key collaborative partner. Showcase of Global USF Health, October 18, 2012, University of South Florida, Tampa, Florida.
  • Nabar NR, Luo Z, Lin X, Cao C & Zhou SF. Efficacy of a therapeutic vaccine using mutated b-amyloid sensitized dendritic cells in Alzheimer’s mice. Showcase of Global USF Health, October 18, 2012, University of South Florida, Tampa, Florida.
  • Liang J, Nabar NR, Guo Q, Xu H & Zhou SF. Osteogenesis of goat bone marrow mesenchymal stem cells induced by transfection of BMP-2 and bFGF. Showcase of Global USF Health, October 18, 2012, University of South Florida, Tampa, Florida.
  • Yin JJ & Zhou SF. Synthesis and functional evaluation of cyclodextrin-folic acid-doxorubicin conjugate for cancer treatment. 2012 AAPS (American Association of Pharmaceutical Scientists) Annual Meeting & Exposition, October 14-18, 2012, McCormick Place, Chicago, IL.
  • Yin JJ & Zhou SF. Synthesis and biological assessment of cyclodextrin-estrone-doxorubicin supramolecule for cancer therapy. 2012 AAPS 2012 AAPS (American Association of Pharmaceutical Scientists) Annual Meeting & Exposition, October 14-18, 2012, McCormick Place, Chicago, IL.
  • Zhou SF. A summary of the goal and mission as the chair of AAPS Focus Group Biotherapeutics ADME from November 2012 to November 2014. 2012 AAPS 2012 AAPS (American Association of Pharmaceutical Scientists) Annual Meeting & Exposition, October 14-18, 2012, McCormick Place, Chicago, IL.
  • Liang J, Chen XW & Zhou SF. Therapeutic efficacy of transplanting magnetically labeled bone marrow stromal stem cells in an acute liver injury rat model. NanoFlorida 2012 – The 5th Nanoscience Technology Symposium: Nanotechnology Frontiers in Medicine, Materials and Energy, September 28-29, 2012, Tampa, Florida.
  • Wang ZX, Volinsky AA, Gallant N & Zhou SF. Polydimethylsiloxane mechanical properties and their effects on cell growth. NanoFlorida 2012 – The 5th Nanoscience Technology Symposium: Nanotechnology Frontiers in Medicine, Materials and Energy, September 28-29, 2012, Tampa, Florida.
  • Wang ZX, Sun JZ, Li MH, Liang J & Zhou SF. A high-throughput screening approach to investigating CYP-drug interactions. NanoFlorida 2012 – The 5th Nanoscience Technology Symposium: Nanotechnology Frontiers in Medicine, Materials and Energy, September 28-29, 2012, Tampa, Florida.
  • Yin JJ, Sharma S, Buzzo R, Shumyak S & Zhou SF. Synthesis and biological evaluation of novel β-cyclodextrin based folic acid receptor targeting drug complex for the therapy of cancer. NanoFlorida 2012 – The 5th Nanoscience Technology Symposium: Nanotechnology Frontiers in Medicine, Materials and Energy, September 28-29, 2012, Tampa, Florida.
  • Yin JJ, Sharma S, Shumyak S & Zhou SF. Preparation and biological evaluation of novel β-cyclodextrin based estrone conjugate drug complex in the treatment of estrogen receptor-positive breast cancer. NanoFlorida 2012 – The 5th Nanoscience Technology Symposium: Nanotechnology Frontiers in Medicine, Materials and Energy, September 28-29, 2012, Tampa, Florida.
  • Yin JJ, Sharma S, Shumyak S & Zhou SF. Design and characterization of novel targeted nanoparticle delivery systems for cancer chemotherapy and implications in personalized medicine. NanoFlorida 2012 – The 5th Nanoscience Technology Symposium: Nanotechnology Frontiers in Medicine, Materials and Energy, September 28-29, 2012, Tampa, Florida.
  • Li Q & Zhou SF. Novel polymeric nanoparticles containing tanshinone-IIA from Chinese herbal medicine: Preparation, characterization, and antitumor activity. NanoFlorida 2012 – The 5th Nanoscience Technology Symposium: Nanotechnology Frontiers in Medicine, Materials and Energy, September 28-29, 2012, Tampa, Florida.
  • Qin YR & Zhou SF. Newly synthesized carbon quantum dots for bioimaging, cancer diagnosis and drug delivery. NanoFlorida 2012 – The 5th Nanoscience Technology Symposium: Nanotechnology Frontiers in Medicine, Materials and Energy, September 28-29, 2012, Tampa, Florida.
  • Liang J, Chen X & Zhou SF. Polymorphisms in folate pathway genes and response to methotrexate treatment in rheumatoid arthritis. American Association of Colleges of Pharmacy (AACP) Annual Meeting, July 14-18, 2012, Kissimmee, Florida.
  • Liang J, Nabar NR, Guo QF, Xu HH & Zhou SF. Osteogenesis of goat bone marrow mesenchymal stem cells induced by transfection of BMP-2 and bFGF.American Association of Colleges of Pharmacy (AACP) Annual Meeting, July 14-18, 2012, Kissimmee, Florida.
  • Nabar NR, Liu CH, Liu C & Zhou SF. Identification of novel genetic polymorphisms in STR loci in two Chinese ethnic minority populations.American Association of Colleges of Pharmacy (AACP) Annual Meeting, July 14-18, 2012, Kissimmee, Florida.
  • Nabar NR, Luo Z, Lin X, Cao C & Zhou SF. Efficacy of a therapeutic vaccine using mutated β-amyloid sensitized dendritic cells in Alzheimer’s mice.American Association of Colleges of Pharmacy (AACP) Annual Meeting, July 14-18, 2012, Kissimmee, Florida.
  • Chen XW, Liang J & Zhou SF. Therapeutic effect of transplanting magnetically labeled bone marrow stromal stem cells in in acute liver injury rat model.American Association of Colleges of Pharmacy (AACP) Annual Meeting, July 14-18, 2012, Kissimmee, Florida.
  • Zhou SF. My experience in teaching pharmacogenetics for pharmacy students across the Pacific.American Association of Colleges of Pharmacy (AACP) Annual Meeting, July 14-18, 2012, Kissimmee, Florida.
  • Wang ZX, Sun JZ, Liang J, Sneed KB & Zhou SF. Rapid screening of potential drug-drug interaction at the CYP1A2, 2C9, 2D6, and 3A4 level.American Association of Colleges of Pharmacy (AACP) Annual Meeting, July 14-18, 2012, Kissimmee, Florida.
  • Sun JZ, Yang L, He L, Liang J & Zhou SF. Repositioning of the FDA-approved tyrosine kinase inhibitors.American Association of Colleges of Pharmacy (AACP) Annual Meeting, July 14-18, 2012, Kissimmee, Florida.
  • Wang ZX, Sneed KB, Liang J & Zhou SF. A computational prediction of microRNAs that regulate human cytochrome P450 genes.American Association of Colleges of Pharmacy (AACP) Annual Meeting, July 14-18, 2012, Kissimmee, Florida.
  • Yin JJ, Sneed KB & Zhou SF. Design and characterization of novel targeted nanoparticle delivery systems for cancer chemotherapy. American Association of Cancer Research (AACR) Annual Meeting, March 31 – April 4, 2012, Chicago, IL.
  • Yin JJ, Sneed KB & Zhou SF. Abstract 5683: Design and characterization of novel targeted nanoparticle delivery systems for cancer chemotherapy. Cancer Res 2012; 72(8, Suppl 1): doi: 10.1158/1538-7445.AM2012-5683; Proceedings of AACR 103rd Annual Meeting Mar 31 -Apr 4, 2012; Chicago, IL.
  • Yin JJ & Zhou SF. Novel targeted cyclodextrin-based nanoparticle delivery system for cancer chemotherapy. Nano-Bio Collaborative International Conference, March 22-24, 2012, Tampa, Florida.
  • Yin JJ & Zhou SF. Preparation and pharmacological evaluation of a novel supramolecular folic acid coupled cyclodextrin delivery system for cancer chemotherapy. Nano-Bio Collaborative International Conference, March 22-24, 2012, Tampa, Florida.
  • Liang J, Chen XW, Sneed KB & Zhou SF. Therapeutic effect of transplanting magnetically labeled bone marrow stromal stem cells in a liver injury rat model with 70%-hepatectomy. Nano-Bio Collaborative International Conference, March 22-24, 2012, Tampa, Florida.
  • Chen CJ, Zhao ZX, Nabar NR, Wang JC, Zhao EY, Gao LY, Zhou SF, Feng Q, Hou WJ, Bai J, Zheng H, Liu XY, Lu WL & Zhang Q. Effects of mixing orders on sirna delivery efficacy for siRNA/redox-responsive hyperbranched poly(amido amine)/hyaluronic acid ternary complex. Nano-Bio Collaborative International Conference, March 22-24, 2012, Tampa, Florida.
  • Li Q & Zhou SF. Novel polymeric nanoparticles containing tanshinone-IIA from Chinese herbal medicine: preparation, characterization, and antitumor activity. Nano-Bio Collaborative International Conference, March 22-24, 2012, Tampa, Florida.
  • Wang ZX, Sun JZ, Liang J, Sneed KB & Zhou SF. Rapid screening of potential drug-drug interactions at the CYP1A2, 2C9, 2D6, and 3A4 levels. Nano-Bio Collaborative International Conference, March 22-24, 2012, Tampa, Florida.
  • Wang ZX, Guzman K, Sneed KB, Liang J & Zhou SF. Computational prediction of microRNAs that regulate Phase I and Phase II drug metabolizing enzymes. Nano-Bio Collaborative International Conference, March 22-24, 2012, Tampa, Florida.
  • Zhou SF. Drug repositioning as an alternative approach of drug discovery through drug-protein interactome and validation studies. USF Bioinformatics Minisymposium – Information, Computation and Health, March 16, 2012, Tampa, Florida.
  • Amin Y, Nabar NR, Wang H, Liu C, Liu C & Zhou SF. A novel method for preparation and application of degraded samples in STR multiplex amplification system. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Chen XW, Liang J, Sneed KB & Zhou SF. Therapeutic effect of transplanting magnetically labeled bone marrow stromal stem cells in a liver injury rat model with 70%-hepatectomy. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Chew H, Wang ZX, Sneed KB, Liang J & Zhou SF. Bioinformatic prediction of microRNAs that regulate human cytochrome P450 genes. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Guzman K, Wang ZX, Liang J, Sneed KB & Zhou SF. Bioinformatic prediction of the microRNAs that regulate ABC transporter genes. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Lai XS, Liang J, Sneed KB & Zhou SF. Proteomic response to acupuncture treatment in spontaneously hypertensive rats. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Le P, Nguyen D, Yang LP, Liang J, Sneed KB & Zhou SF. Identification of herbal inhibitors for human cytochrome P450 1A2 and implication in herb-drug interactions. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Li MH, Wang ZX, Sun JZ, Liang J, Sneed KB & Zhou SF. A high throughput screening approach to investigating how nuclear receptor ligands affect human cytochrome P450s. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Li Q & Zhou SF. Novel polymeric nanoparticles containing tanshinone-IIA from Chinese herbal medicine: Preparation, characterization, and antitumor activity. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Liang J, Nabar NR, Guo Q, Xu H & Zhou SF. Osteogenesis of goat bone marrow mesenchymal stem cells induced by transfection of BMP-2 and bFGF. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Luo RJ & Zhou SF. Metabonomics study on human hepatocarcinoma cells treated with tyrosine kinase inhibitors. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Muscarella MN, Andruski B, He QL, Liang J, Sun LB & Zhou SF. Osthole alleviates nucleus pulposus-evoked nociceptive responses through the suppression of overexpression of acid-sensing ion channel 3 in rat dorsal root ganglion. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Nabar NR, Luo Z, Lin X, Cao C & Zhou SF. A murine study of a novel vaccine using mutated β-amyloid sensitized dendritic cells in Alzheimer’s disease. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Naif AK, Patel AR, Mo XL, Chen X, Liang J & Zhou SF. Polymorphisms in folate pathway genes and response to methotrexate treatment in rheumatoid arthritis. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Panchal J, Nabar NR, Nabar NR, Bai G, Cao CH, Liang J & Zhou SF. A novel, multi-component, multi-targeted “cocktail” from natural products for the treatment of Alzheimer’s disease. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Pathak S, Kang KF, Liang J & Zhou SF. Beclin 1 and nuclear factor-κBp65 as potential biomarkers for hepatocellular carcinoma. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Pradeep N, Nabar NR, Liu CH, Liang J & Zhou SF. Identification of novel genetic polymorphisms in short tandem repeat loci in two ethnic minority populations in China. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Sun JZ, Yang L, Li MH, Wang ZX, Wright EM, Howell CE, Sneed KB & Zhou SF. Repositioning of the FDA-approved tyrosine kinase inhibitors targeting histone deacetylases, B-Raf and other proteins. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Vachon DM, Mo SL, Sneed KB, Liang J & Zhou SF. Identification of ligands for human cytochrome P450 2D6 using virtual screening and molecular modeling. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Wang ZX, Sun JZ, Liang J, Sneed KB & Zhou SF. High throughput screening to investigate the effect of a library of kinase inhibitors on clinically important cytochrome P450s: an efficient tool to identify drug-drug interactions. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Yin JJ & Zhou SF. Novel targeted cyclodextrin based nanoparticle delivery systems for cancer chemotherapy. 22nd Annual USF Health Research Day, February 24, 2012, Tampa, Florida.
  • Naif AK, Patel AR, Mo XL, Chen X, Liang J & Zhou SF. Polymorphisms in folate pathway genes and response to methotrexate treatment in rheumatoid arthritis. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Vachon DM, Mo SL, Sneed KB, Liang J & Zhou SF. Identification of ligands for human cytochrome P450 2D6 using virtual screening and molecular modeling. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Sun JZ, Yang L, Li MH, Wang ZX, Wright EM, Howell CE, Sneed KB & Zhou SF. Repositioning of the FDA-approved tyrosine kinase inhibitors targeting histone deacetylases, B-Raf and other proteins. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Yin JJ & Zhou SF. Novel targeted cyclodextrin based nanoparticle delivery systems for cancer chemotherapy. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Liang J, Wang LL, Sneed KB & Zhou SF. Predicting the phenotype of deleterious non-synonymous SNPs in human alcohol metabolism-related genes. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Liang J, Nabar NR, Guo Q, Xu H & Zhou SF. Osteogenesis of goat bone marrow mesenchymal stem cells induced by transfection of BMP-2 and bFGF. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Guzman K, Wang ZX, Liang J, Sneed KB & Zhou SF. Bioinformatic prediction of the microRNAs that regulate ABC transporter genes. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Muscarella MN, Andruski B, He QL, Liang J, Sun LB & Zhou SF. Osthole alleviates nucleus pulposus-evoked nociceptive responses through the suppression of overexpression of acid-sensing ion channel 3 in rat dorsal root ganglion. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Nabar NR, Luo Z, Lin X, Cao C & Zhou SF. A murine study of a novel vaccine using mutated β-amyloid sensitized dendritic cells in Alzheimer’s disease. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Nabar NR, Zhang Z, Bai G, Cao C, Liang J, Sneed KB & Zhou SF. A novel, multi-component, multi-targeted “cocktail” from natural products for the treatment of Alzheimer’s disease. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Nabar NR, Liu CH, Liang J & Zhou SF. Identification of novel genetic polymorphisms in short tandem repeat loci in two ethnic minority populations in China. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Le P, Nguyen D, Yang LP, Liang J, Sneed KB & Zhou SF. Identification of herbal inhibitors for human cytochrome P450 1A2 and implication in herb-drug interactions. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Li Q & Zhou SF. Novel polymeric nanoparticles containing tanshinone-IIA from Chinese herbal medicine: preparation, characterization, and antitumor activity. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Luo RJ & Zhou SF. Identification of novel biomarkers for cancer and pharmacotherapy using the metabolomics approach. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Luo RJ & Zhou SF. Metabonomics study on human hepatocarcinoma cells treated with tyrosine kinase inhibitors. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Pathak S, Kang KF, Liang J & Zhou SF. Beclin 1 and nuclear factor-κBp65 as potential biomarkers for hepatocellular carcinoma. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Chen XW, Liang J & Zhou SF. Therapeutic effect of transplanting magnetically labeled bone marrow stromal stem cells in a liver injury rat model with 70%-hepatectomy. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Lai XS, Liang J, Sneed KB & Zhou SF. Proteomic response to acupuncture treatment in spontaneously hypertensive rats. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Wang ZX, Sun JZ, Liang J, Sneed KB & Zhou SF. High throughput screening to investigate the effect of kinase inhibitors on important cytochrome P450s. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Wang ZX, Sun JZ, Liang J, Sneed KB, & Zhou SF. A high throughput screening approach to investigating how nuclear receptor ligands affect human cytochrome P450s. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Wang ZX, Sneed KB, Liang J & Zhou SF. Bioinformatic prediction of microRNAs that regulate human cytochrome P450 genes. The National Academy of Inventors (NAI) Inaugural Annual Conference, February 16-17, 2012, Tampa, Florida.
  • Yang LP, Zhou ZW, & Zhou SF. Computational and in vitro studies on the inhibitory effects of herbal compounds on human cytochrome P450 1A2. The 24th American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, October 23-27, 2011, Washington DC.
  • Mo SL, Liu WF, Chen Y & Zhou SF. Ligand-and protein-based modeling studies of inhibitors of human cytochrome P450 2D6 and virtual screening of the Chinese herbal medicine, Scutellaria Baicalensis (Huangqin, baikal skullcap). The 24thThe 24th American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition, October 23-27, 2011, Washington DC.
  • Zhou SF. My experience in teaching pharmacogenetics for pharmacy students across the Pacific. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Zhou SF. Pharmacogenomics and individualized pharmacotherapy: from drug metabolizing enzymes, drug transporters to drug targets. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Patel AR, Naif AK, Sneed KB & Zhou SF. TargetScan prediction of miRNA-mediated regulation of human nuclear receptor genes. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Daley AM, Sneed KB & Zhou SF. Pharmacogenetics of human thiopurine S-methyltransferase: an update. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Nguyen AM, Sneed KB, Serag ES & Zhou SF. Genotype-phenotype relationships of the human cytochrome P450 1A2 gene. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Naif AK, Patel AR, Mo XL, Chen J, Li JL, Ren B, Yun G, Yang XY, Huang M, Chen X, Liang J & Zhou SF. Impact of polymorphisms of the genes from the folate pathway on response of patients with rheumatoid arthritis to methotrexate treatment. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Zall DL, Sneed KB, Serag ES & Zhou SF. Clinical pharmacogenetics of the human cytochrome P450 2D6 gene: a systematic literature search. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Vachon DM, Mo SL, Sneed KB, Liang J & Zhou SF. A molecular modeling and virtual mutation study for the polymorphic human cytochrome P450 2D6 (CYP2D6). The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Nguyen D, Wang ZX, Le P, Sneed KB, & Zhou SF. Predicting the miRNAs possibly regulating human uridine diphospho-glucuronosyltransferase (UGT) genes via TargetScan. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Wright EM, Sneed KB, Serag ES & Zhou SF. Clinical pharmacogenomics, individualized pharmacotherapy and personalized medicine. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Sun JZ, Wang ZX, Sneed KB & Zhou SF. Structure-activity relationship studies on the effect of kinase inhibitors on clinically important drug metabolizing enzymes, transporters and targets: an in vitro, in silico and in vivo study and implications in personalized medicine. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Yin JJ, Sneed KB & Zhou SF. Design and characterization of novel targeted nanoparticle delivery systems for cancer chemotherapy and implications in personalized medicine. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Liang J, Wang LL, Sneed KB & Zhou SF. Phenotype prediction of deleterious non-synonymous SNPs in human alcohol metabolism-related genes using a bioinformatics approach. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Ismail M, Serag ES, Liang J, Sneed KB & Zhou SF. Clinical impact of human cytochrome P450 2C9 polymorphisms: a systematic review. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Muscarella MN, Andruski B, He QL, Liang J, Sun LB & Zhou SF. Osthole, a herbal compound, alleviates nucleus pulposus-evoked nociceptive responses through the suppression of overexpression of acid-sensing ion channel 3 (ASIC3) in rat dorsal root ganglion. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Nabar NR, Luo Z, Lin X, Cao C &SF Zhou. Efficacy of a therapeutic vaccine using mutated β-amyloid sensitized dendritic cells in Alzheimer’s mice. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Nabar NR, Zhang Z, Bai G, Cao C, Sneed KB & Zhou SF. Development of a novel, multi-component, multi-targeted “cocktail” from natural products for the treatment of Alzheimer’s disease. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Le P, Nguyen D, Yang LP, Liang J, Sneed KB & Zhou SF. Identification of herbal inhibitors for the polymorphic human cytochrome P450 1A2 (CYP1A2) and implications in herb-drug interactions. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Belz RC, Chen XW, Zhu DJ, Ju YL & Zhou SF. Therapeutic effect of transplanting magnetically labeled bone marrow stromal stem cells in a rat liver injury model with 70%-hepatectomy. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Luo RJ, Sun JZ, Cao C, Sneed KB & Zhou SF. Identification of novel biomarkers in clinically important diseases and pharmacotherapy using the metabolomics approach. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Amin YH, Liu YH & Zhou SF. Prediction of functional effects of non-synonymous SNPs in human nuclear receptor genes using a bioinformatics method. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Wang ZX, Sneed KB, Liang J & Zhou SF. A computational prediction of microRNAs that regulate human cytochrome P450 genes. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Guzman K, Wang ZX, Sneed KB & Zhou SF. Application of bioinformatics to predict the microRNAs that possibly regulate ABC transporter genes. The 1st International Conference on Developmental, Translational and Clinical Pharmacogenomics, September 22-24, 2011, Tampa, Florida.
  • Zhou SF. Drug discovery, nanoformulation and genetic polymorphisms. Symposium on drug discovery in the postgenomic era, June 17, 2011, USF, Tampa, Florida.
  • Zhou SF& He SM. Abstract 900: Tissue CA125 expression levels as a biomarker of endometrial cancer. Cancer Research: April 15, 2011; Volume 71, Issue 8, Supplement 1 doi: 10.1158/1538-7445.AM2011-900. Proceedings: AACR 102nd Annual Meeting 2011 — Apr 2-6, 2011; Orlando, FL.
  • He SM & Zhou SF. Endometrial CA125 expression levels as a biomarker of endometrial cancer in Chinese women. The 102nd American Association of Cancer Research (AACR) Annual Conference, April 2-6, 2011, Orlando, Florida.
  • Zhang Z, Sun G, Zhang Q, Sun M & Zhou SF. Modified Xiao Qing Long decoction improves pulmonary function in ventilation-restricted rabbits. 21st Annual USF Health Research Day, February 25, 2011, Tampa, FL 33612.
  • Sui H, Zhou L, Wang Y, Fan Z, Li Q & Zhou SF. COX-2 contributes to P-glycoprotein–mediated multidrug resistance via JNK signal transduction pathway in HCT8/V cells. 21st Annual USF Health Research Day, February 25, 2011, Tampa, FL 33612.
  • Zhou SF. Phenotype prediction of non-synonymous single nucleotide polymorphisms in human ATP-binding cassette (ABC) transporter genes. Inaugural RMIT School of Health Sciences and School of Medical Sciences Research Conference, July 9, 2010, Melbourne, Victoria, Australia.
  • Li YH, Li CG & Zhou SF. Several natural compounds from Chinese herb medicine can affect pregnane X receptor-mediated CYP3A4 gene expression. Inaugural RMIT School of Health Sciences and School of Medical Sciences Research Conference, July 9, 2010, Melbourne, Victoria, Australia.
  • Cai GH, Zhou SF& Li CG. Relationship of cellular nitric oxide production to protections of natural compounds against doxorubicin-induced cardiotoxicity. Inaugural RMIT School of Health Sciences and School of Medical Sciences Research Conference, July 9, 2010, Melbourne, Victoria, Australia.
  • Zhai XF, Shen Y, Zhou SF& Li CG. Quality control of a Chinese herbal medicine for COPD by HPLC fingerprinting. Inaugural RMIT School of Health Sciences and School of Medical Sciences Research Conference, July 9, 2010, Melbourne, Victoria, Australia.
  • Zhou ZW, Zhou SF& Li CG. In silico prediction of the biological fate and toxicity of Chinese herbal compounds. Inaugural RMIT School of Health Sciences and School of Medical Sciences Research Conference, July 9, 2010, Melbourne, Victoria, Australia.
  • Di YM, Li CG & Zhou SF. Identification of current and future therapeutic targets of rheumatic arthritis by a bioinformatic approach. Inaugural RMIT School of Health Sciences and School of Medical Sciences Research Conference, July 9, 2010, Melbourne, Victoria, Australia.
  • Di YM, Li CG & Zhou SF. Do Chinese herbal medicines act through a network of molecular targets? The 6th World Congress of Chinese Medicine, December 5-6, 2009, Melbourne, Victoria, Australia.
  • Zhou SF. Molecular targets of herbal medicines. The 6th World Congress of Chinese Medicine, December 5-6, 2009, Melbourne, Victoria, Australia.
  • HJ Jin, Zhou SF& Li CG. Role of mitochondria permeability transition pore pathway in cardioprotections induced by bioactive compounds from Salvia miltiorrhiza. The 6th World Congress of Chinese Medicine, December 5-6, 2009, Melbourne, Victoria, Australia.
  • Zhou ZW, Xue CL, Zhou SF& Li CG. A systematic review: Clinical pharmacokinetics of herbal medicines. The 6th World Congress of Chinese Medicine, December 5-6, 2009, Melbourne, Victoria, Australia.
  • Di YM, Li CG & Zhou SF. Do Chinese herbal medicines act through a network of molecular targets? RMIT Science, Engineering and Health Higher Degrees by Research (HDR) Students Conference, October 23, 2009, Melbourne, Victoria, Australia.
  • Cai GH, Zhou SF& Li CG. Design and test of novel plant-derived natural compounds to prevent or reduce drug-induced cardiotoxicity.RMIT Science, Engineering and Health Higher Degrees by Research (HDR) Students Conference, October 23, 2009, Melbourne, Victoria, Australia.
  • O’Loughlan M, Zhou SF& Li CG. Salvia miltiorrhiza (danshen) attenuates superoxide production through activation of NADPH oxidases in rat aorta and rat heart. 5th RMIT University School of Health Sciences Research Conference, July 16, 2009, Melbourne, Victoria, Australia.
  • Jin H, Zhou SF& Li CG. Role of mitochodrial permeability transition pore pathway in cardioprotections induced by bioactive compounds from Salvia miltiorrhiza. 5th RMIT University School of Health Sciences Research Conference, July 16, 2009, Melbourne, Victoria, Australia.
  • Di YM, Chan E, Wei MQ, Liu JP, Li CG & Zhou SF. Prediction of deleterious non-synonymous single nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genes. 5th RMIT University School of Health Sciences Research Conference, July 16, 2009, Melbourne, Victoria, Australia.
  • Cao GH, Zhou SF& Li CG. Modulation of NO pathways by Chinese herbal medicines. 5th RMIT University School of Health Sciences Research Conference, July 16, 2009, Melbourne, Victoria, Australia.
  • Zhou YL, Zhou SF& Li CG. TNF-a antagonists reduce radiological progression in patients with active rheumatoid arthritis: a systemic review and meta-analysis of randomized controlled trials. 5th RMIT University School of Health Sciences Research Conference, July 16, 2009, Melbourne, Victoria, Australia.
  • Zhou ZW, Zhou SF& LiCG. Investigation of molecular determinants of CYP2C9-ligand interaction and CYP2C9 regulation: implication for drug-drug and herb-drug interactions. 5th RMIT University School of Health Sciences Research Conference, July 16, 2009, Melbourne, Victoria, Australia.
  • Zhou SF. Use of nanotechnology to improve the efficacy and bioavailability of anticancer drugs. 2nd Australia-China Biomedical Research Conference (ACBRC 2009), April 23-27, 2009, Tianjin & Guangzhou, Guangdong, China.
  • Di YM, Wang LL & Zhou SF. Prediction of deleterious non-synonymous single nucleotide polymorphisms of uridine diphosphate glucuronosyltransferase. The Australian Health and Medical Research Congress, November 17-21, 2008, Brisbane, Queensland, Australia.
  • Liu YH, Wang LL, Li CG & Zhou SF. Prediction of deleterious functional Effects of non-synonymous single nucleotide polymorphisms for human nuclear receptors using bioinformatics approach. The Australian Health and Medical Research Congress, November 17-21, 2008, Brisbane, Queensland, Australia.
  • Yang LP, Zhou SF& Li CG. A pharmacophore model for the inhibitors of CYP2C9. International Conference on Integrated Traditional Medicine for Cardiovascular System, October 25-28, 2009, Beijing, China.
  • Zhou SF. Ganoderma lucidum in cancer treatment: promise and challenge. The 3rd International Symposium of East-West Medicine for Cancer Therapy, October 31 – November 2, 2008, Seoul, Korea.
  • Zhou SF. Nanoparticle-based technology for the targeted delivery of anticancer drugs. The 2nd Australia-China Symposium on Science, Technology and Education, October 15-18, 2008, Gold Coast, Queensland, Australia.
  • Wang LL, Li Y & Zhou SF. Prediction of deleterious non-synonymous single nucleotide polymorphisms of genes related to ethanol-induced toxicity. 4th RMIT University School of Health Sciences Research Conference, July 16 2008, Melbourne, Victoria, Australia.
  • Chow VDW, Li CG & Zhou SF. A novel self-microemulsifying drug delivery system for enhancement of the anticancer activity of camptothecins.  4th RMITUniversity School of Health Sciences Research Conference, July 16, 2008, Melbourne (Bundoora), Victoria, Australia.
  • O’Loughlan M, Zhou SF& Li CG. Role of tetrahydrobiopterin in cardioprotective actions of Salvia miltiorrhiza (danshen). 4th RMIT University School of Health Sciences Research Conference, July 16, 2008, Melbourne (Bundoora), Victoria, Australia.
  • Di YM, Li CG & Zhou SF. Improving the antitumour activity of cytotoxic drugs with RGD-based strategies. 4th RMIT University School of Health Sciences Research Conference, July 16, 2008, Melbourne (Bundoora), Victoria, Australia.
  • Zhou SF. Recent progress in the application of evidence-based application of herbal medicines for the treatment of cardiovascular diseases. 10th South China International Cardiovascular Conference, April 10-12, 2008, Guangzhou, Guangdong, China.
  • Liu WH, Tang FT, Nie H, Huang HQ, Li XJ, Liu PQ, Li CG, Xue CCL & Zhou SF. Berberine ameliorates renal injury in streptozotocin-induced diabetic rats through suppression of both oxidative stress and aldose reductase. 3rd International Congress on Complementary Medicine Research(ICCMR), March 29-31, 2008, Sydney, New South Wales, Australia.
  • Wang LL, Zhang Z, Li Q, Xu Y, Wang J, Yang R, Pei X, Zhou SF& Li Y. MicroRNA miR-10a correlates with birth defects induced by ethanol and with the prevention of folic acid supplement.3rd International Congress on Complementary Medicine Research (ICCMR), March 29-31, 2008, Sydney, New South Wales, Australia.
  • Bi HC, Zuo Z, Chen X, Huang M, Li CG, Xue CCL & Zhou SF. Preclinical factors affecting the pharmacokinetic behaviors of tanshinone IIA, an investigational new drug purified from danshen (Salvia miltiorrhiza) for treatment of ischemic heart diseases. 3rd International Congress on Complementary Medicine Research (ICCMR), March 29-31, 2008, Sydney, New South Wales, Australia.
  • Zhou SF. Evidence-based application of multi-component Chinese herbal medicines. ASCEPT (Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists) Annual Conference (10th Annual Meeting of The Southeast Asian Western Pacific Regional Federation of Pharmacologists (SEAWP-RFP)), December 3-6, 2007, Adelaide, South Australia, Australia.
  • Zhou SF. Metabolism and transport of drugs and Chinese herbal medicines: from molecule to malady. First International Symposium on Quantitative Pharmacology in Drug Development and Regulatory Sciences, October 29-31, 2007, Nanjing, China.
  • Weng JY, Zhou SF, Craig B & Alany RG.  Transdermal delivery of l-glutathione by lipid based systems. 67th International Pharmaceutical Federation (FIP) Congress, August 31 - September 6, 2007, Beijing, China.
  • Weng JY, Zhou SF, Craig B & Zhou Y.  Oral delivery of L-glutathione by novel delivery systems. 67th International Pharmaceutical Federation (FIP) Congress, August 31 - September 6, 2007,Beijing, China.
  • Zhou SF. Cardiovascular pharmacogenomics in the SNP era. 9th South China International Cardiovascular Conference, April 4-8, 2007, Guangzhou, Guangdong, China.
  • Weng JY, Zhou SF, Du D, Lee DJ, Ahn SJ, Mistry H, Kapadia D, Ann HY, Bian AR & Alany RG. Transdermal delivery of l-glutathione by lipid based delivery system. 9th Dunedin Conference on Formulation and Delivery of Bioactives, February 15-16, 2007, Dunedin, New Zealand.
  • Weng JY, Zhou SF, Du D & Alany RG. Imaging techniques application in drug delivery. 9th Dunedin Conference on Formulation and Delivery of Bioactives, February 15-16, 2007, Dunedin, New Zealand.
  • Weng JY,Chan AH, Zhou SF& Alany R.  Oral delivery of L-glutathione by nanoparticular system. Proceedings of 9th Dunedin Conference on Formulation and Delivery of Bioactives, February 15-16, 2007,Dunedin, New Zealand, p41.
  • Weng JY, Chan AHY, Zhou SF& Alany RG. Oral delivery of L-glutathione by nanoparticular system. 9th Dunedin Conference on Formulation and Delivery of Bioactives, February 15-16, 2007, Dunedin, New Zealand.
  • Weng JY, Zhou SF, Du D, Zhou YZ & Alany R. Formulation and characterization of nanoparticulate systems for oral delivery of L-Glutathione. Proceedings of the 34rd Annual Meeting and Exposition of the Controlled Release Society, July 22-26, 2006, Long Beach, CA (Poster 423).
  • Zhou SF. Mechanism for the transport of active herbal constituents across the blood-brain barrier: experience with tanshinones in Salvia miltiorrhiza (danshen) and beyond. 7th Biennial Meeting of the Asian Pacific Society for Neurochemistry (APSN 2006), July 2-5, 2006, Singapore.
  • Hu ZP, Yang XX & Zhou SF. Combination of St John’s wort with irinotecan. 18th Singapore Pharmacy Congress, June 30 - 3 July 3, 2006, Singapore.
  • Yang XX, Hu ZP & Zhou SF. Pharmacokinetic and pharmacodynamic interactions of thalidomide with irinotecan. 18th Singapore Pharmacy Congress, June 30 - July 3, 2006, Singapore.
  • Tian Q, Zhang J & Zhou SF. MRP3 and camptothecins. 18th Singapore Pharmacy Congress, June 30 - July 3, 2006, Singapore.
  • Zhang J, Tian Q & Zhou SF. MRPs and oxazaphosphorines. 18th Singapore Pharmacy Congress, June 30 - July 3, 2006, Singapore.
  • Sun F, Yu Q & Zhou SF. Screening of novel anticancer drugs in vitro. 18th Singapore Pharmacy Congress, June 30 - July 3, 2006, Singapore.
  • Zhou SF. Herbal development: challenge and strategies. 18th Singapore Pharmacy Congress, June 30 -  July 3, 2006, Singapore.
  • Wong SA, Tian Q & Zhou SF. Multidrug resistance associated protein 4 confers significant resistance to topotecan. Annual Final Year Project (FYP) Symposium, March 30, 2006, Singapore.
  • Zhou SF, Zhong SL, Chen X & Huang M. Relationship between genotype and enzyme activity of glutathione S-transferases in Chinese. Joint 6th Human Genome Organization (HUGO) Pacific Meeting & 7th Asia-Pacific Human Genetics Conference (HUGO-AP 2006), March 6-10, 2006, Taipei, Taiwan.
  • Zhou SF. Future studies of herbal drug interaction: prevent and predict. Health Canada International Symposium on Drug, Food and Natural Health Product Interactions, February 8-12, 2006, Ottawa, Canada.
  • Ong CL, Tian Q & Zhou SF. Multidrug resistance associated protein 4 confers resistance to 10-hydroxy-camptothecin. NUS Undergraduates Research Opportunity Program (NUROP) Congress, February 18, 2006, Singapore.
  • Zhang J, Tian Q & Zhou SF. Analysis of oxazaphosphorine anticancer drugs’ sensitivity in HepG2 cells overexpressing MRP4. AAPS-NUS Student Chapter Symposium, January 12, 2006, Singapore.
  • Tian Q, Zhang J, Tan MQ, Chan SY, Chan E, Duan W & Zhou SF. Human multidrug resistance associated protein 4 confers resistance to camptothecins. AAPS-NUS Student Chapter Symposium, January 12, 2006, Singapore.
  • Hu ZP, Yang XX & Zhou SF. Pharmacokinetics of recombinant human endostatin in rats. AAPS-NUS Student Chapter Symposium, January 12, 2006, Singapore.
  • Yang XX, Hu ZP, Chan SY & Zhou SF. Thalidomide attenuates chemotherapy-induced intestinal lesions via down-regulation of TNF-a and abrogation of intestinal epithelial apoptosis.AAPS-NUS Student Chapter Symposium, January 12, 2006, Singapore.
  • Hu ZP, Yang XX, Chan SY & Zhou SF. Combination with St. John’s wort alleviated dose-limiting toxicities of CPT-11 in rats: A mechanistic study. The First Mathematics and Physical Science Graduate Congress, December 6-8, 2005, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
  • Yang XX, Hu ZP, Chan SY, Goh BC, Chan E & Zhou SF. Pharmacokinetic interactions between CPT-11 and thalidomide. The First Mathematics and Physical Science Graduate Congress, December 6-8, 2005, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
  • Tian Q, Zhang J, Tan MQ, Chan E, Chan SY, Duan W & Zhou SF. Human multidrug resistance associated protein 4 confers resistance to camptothecins. 1st Postgraduate Congress of Faculty of Science of NUS, September 21-22, 2005, Singapore.
  • Yang XX, Hu ZP, Chan SY, Goh BC & Zhou SF. Pharmacokinetics interactions between CPT-11 and thalidomide in rats. 1st Postgraduate Congress of Faculty of Science of NUS, September 21-22, 2005, Singapore.
  • Yang XX, Hu ZP, Chan SY & Zhou SF. Thalidomide alters the Pharmacokinetics of irinotecan and a mechanistic study. Inaugural AAPS-NUS Student Chapter Symposium, September 16, 2005, Singapore.
  • Hu ZP, Yang XX, Ho PC, Chan SY & Zhou SF. Combined St John’s wort alleviates the toxicity of irinotecan. Inaugural AAPS-NUS Student Chapter Symposium, September 16, 2005, Singapore.
  • Zhang J, Tian Q & Zhou SF. Resistance profiles of multidrug resistance associated protein 4 to anticancer drugs. Inaugural AAPS-NUS Student Chapter Symposium, September 16, 2005, Singapore.
  • Tian Q, Zhang J & Zhou SF. Multidrug resistance associated protein 4 confers resistance to camptothecins. Inaugural AAPS-NUS Student Chapter Symposium, September 16, 2005, Singapore.
  • Wong SA, Tian Q & Zhou SF. Multidrug resistance associated protein 4 confers resistance to the topoisomerase I inhibitor topotecan. Inaugural AAPS-NUS Student Chapter Symposium, September 16, 2005, Singapore.
  • Yang XX, Hu ZP, Chan SY, Goh BC, Chan E, Koh HL & Zhou SF. Pharmacokinetics interactions between CPT-11 and thalidomide. 17th Singapore Pharmacy Congress, June 30 - July 3, 2005, Singapore.
  • Hu ZP, Yang XX, Ho PC, Chan SY, Chan E, Koh HL & Zhou SF. Combination with St John’s wort alleviates dose-limiting toxicities of irinotecan (CPT-11) in rats. 17th Singapore Pharmacy Congress, June 30 – 3 July 3, 2005, Singapore.
  • Chen X, Hegde A, Zhou SF, Kol HL & Chan E. 17th Singapore Pharmacy Congress, 30 June - 3 July 2005, Singapore.
  • Chua TK, Lau AJ, Pang YK, Chan E, Zhou SF& Koh HL. In vitro inhibitory effects of Southeast Asian medicinal plants on platelet-aggregation and blood plasma coagulation. 17th Singapore Pharmacy Congress, 30 June - 3 July 2005, Singapore.
  • Ganeswari A/P Apparow, Tian Q & Zhou SF. Multidrug resistance associated protein 4 confers resistance to rubitecan. 17th Singapore Pharmacy Congress, 30 June - 3 July 2005, Singapore.
  • Ong CL, Tian Q & Zhou SF. Multidrug resistance associated protein 4 confers resistance to 10-hydroxy-camptothecin. 17th Singapore Pharmacy Congress, 30 June - 3 July 2005, Singapore.
  • Wong SA, Tian Q & Zhou SF. Multidrug resistance associated protein 4 confers resistance to topotecan. 17th Singapore Pharmacy Congress, 30 June - 3 July 2005, Singapore.
  • Zhang J, Tian Q & Zhou SF. Resistance profiles of multidrug resistance associated protein 4 to anticancer drugs. 17th Singapore Pharmacy Congress, 30 June - 3 July 2005, Singapore.
  • Zheng L, Huynh H, Zhou SF& Chan E. A pilot study on potential synergistic effects of COL-3 and tamoxifen given concurrently using an animal model. 17th Singapore Pharmacy Congress, 30 June - 3 July 2005, Singapore.
  • Tian Q, Zhang J, Tan MQ, Chan E, Chan SY & Zhou SF. Resistance profiles of camptothecins in HepG2 cells with overexpression of MRP4. 17th Singapore Pharmacy Congress, 30 June - 3 July 2005, Singapore.
  • Suhaiemi TN, Zhang J & Zhou SF. Multidrug resistance associated protein 4 (MRP4) confers resistance to cyclophosphamide. 17th Singapore Pharmacy Congress, June 30 - July 3, 2005, Singapore.
  • Zhou SF, Hu ZP, Yang XX, HO PC, Koh HL & Chan E. The herbal antidepressant St. John’s wort modulates the dose-limiting toxicities and pharmacokinetics of the anticancer drug CPT-11 (irinotecan) in rats. International Conference on Complementary and Alternative Medicine (ICCAM), February 26-28, 2005, Singapore.
  • Zhou SF, Chan E, Huang M, Koh HL, Li XT & Gao YH. Antitumor activity and underlying mechanisms of Ganopoly, the refined polysaccharides extracted from Ganoderma lucidum, in mice. International Conference on Complementary and Alternative Medicine (ICCAM), February 26-28, 2005, Singapore.
  • Zhou SF, Zhong SL & Huang M. A genotyping study of glutathione S-transferase genes in healthy Han and Uygur Chinese. 3rd International Conference on Structural Biology and Functional Genomics, December 2-4, 2004, Singapore.
  • Tian Q, Tan MQ, Chan E, Hung Y, Lim LY & Zhou SF. Sensitivity of camptothecins in HepG2 cells overexpressing multidrug resistance associated protein 4. 3rd International Conference on Structural Biology and Functional Genomics, December 2-4, 2004, Singapore.
  • Hu ZP, Yang XX, Ho PS, Chan SY, Chan E & Zhou SF. St. John's wort alleviates the toxicities of irinotecan (CPT-11) in rats. 3rd International Conference on Structural Biology and Functional Genomics, December 2-4, 2004, Singapore.
  • Yang XX, Hu ZP, Chan SY, Chan E, Goh BC & Zhou SF. Thalidomide modulates the toxicity and pharmacokinetics of CPT-11. 3rd International Conference on Structural Biology and Functional Genomics, December 2-4, 2004, Singapore.
  • Tian Q, Tan MQ, Chan E, Hung Y, Lim LY & Zhou SF. Resistance profile of CPTs in multidrug resistance associated protein 4. 5th HUGO Pacific Meeting & 6th Asia-Pacific Conference on Human Genetics, November 17-20, 2004, Singapore.
  • Zhou SF, Zhong SL & Huang M. A comparison of glutathione S-transferase mutant frequencies in healthy Han and Uygur Chinese. 5th HUGO Pacific Meeting & 6th Asia-Pacific Conference on Human Genetics, November 17-20, 2004, Singapore.
  • Hu ZP, Yang XX, Ho PS, Chan SY, Chan E & Zhou SF. Combination with St. John's wort alleviated dose-limiting toxicities of irinotecan (CPT-11) in rats. 2004 AAPS Annual Meeting and Exposition, November 7-11, 2004, Baltimore, MD.
  • Yang XX, Hu ZP, Chan SY, Chan E, Goh BC & Zhou SF. A combination study for CPT-11 with thalidomide. 2004 AAPS Annual Meeting and Exposition, November 7-11, 2004, Baltimore, MD.
  • Zhou SF&Gao YH. Clinical studies of herbal medicines: challenges and strategies.  3rd International Conference on Natural Products, October 22-25, 2004, Nanjing, Jiangsu, China.
  • Lou HX, Yau WP, Vathsala A, Sy J, Zhou SF& Chan E. Pharmacokinetics of mycophenolic acid in renal transplant recipients in Singapore. 4th Singapore Health Science Meeting, October 11-13, 2004, Singapore.
  • Paxton JW, Kestell P, Chiang D, & Zhou SF& Lewis DFV. Inhibition of human CYP1A2 oxidation of 5,6-dimethyl-xanthenone-4-acetic acid (DMXAA) by acridines: a molecular modeling study. 8th World Congress on Clinical Pharmacology and Therapeutics, August 1-6, 2004, Brisbane, Queensland, Australian.
  • Zhou SF, Gao YH, Huang M, Ye JX, Dai XH & Du YM. Chinese herbal medicine for the treatment of chronic hepatitis B virus infection and experience with Lingzhi (Ganoderma lucidum). The 3rd Association of Pacific Rim Universities (APRU), 7-9 July 2004, Fudan University, Shanghai, China.
  • Zhou SF, Yang XX, Hu ZP, Chan SY, Chan E & Goh BC. Thalidomide, a tumor necrosis factor-a inhibitor, ameliorated the dose-limiting toxicity of irinotecan (CPT-11) in the rats. Inaugural Association of Asian School of Pharmacy (AASP) Conference, 4-6 June, 2004, Beijing, China.
  • Yang XX, Hu ZP, Chan SY, Chan E, Goh BC & Zhou SF. A Combination study for CPT-11 with thalidomide. The 3rd Pacific Anti-ageing Conference and Exhibition, 24-27 June 2004, Singapore.
  • Hu ZP, Zhou SF, Yang XX & Li B. Pharmacokinetics, tissue distribution and excretion of recombinant human parathyroid hormone 1-34 after subcutaneous and intravenous administration in Rhesus monkeys and Wistar rats. The 3rd Pacific Anti-ageing Conference and Exhibition, 24-27 June 2004, Singapore.
  • Tian Q, Tan MQ & Zhou SF. Overexpression of multi-drug resistance-associated protein 4 (MRP4) confers resistance to camptothecins in HepG2 cells. The 3rd Pacific Anti-ageing Conference and Exhibition, June 24-27, 2004, Singapore.
  • Hu ZP, Yang XX, Ho PC, Chan SY, Chan E & Zhou SF. Combination with St John's wort alleviated dose-limiting toxicities of irinotecan (CPT-11) in rats. The 3rd Pacific Anti-ageing Conference and Exhibition, June 24-27, 2004, Singapore.
  • Hu ZP, Yang XX, Ho PC, Chan SY, Chan E & Zhou SF. Combination with St John's wort alleviated dose-limiting toxicities of irinotecan (CPT-11) in the rat. HSA-NUS Joint Scientific Symposium, May 19, 2004, Singapore.
  • Zhou SF, Chan E, Koh HL &Gao YH. Development of herbal medicines: Experience with Ganoderma lucidum (Ling-Zhi). HSA-NUS Joint Scientific Symposium, May 19, 2004, Singapore.
  • Yang XX, Hu ZP, Chan SY, Chan E, Ho PC & Zhou SF. Combination of thalidomide alleviated the dose-limiting toxicities of CPT-11 in the rat. HSA-NUS Joint Scientific Symposium, May 19, 2004, Singapore.
  • Tian Q, Tan MQ & Zhou SF. Overexpression of MRP4 confers resistance to camptothecins in HepG2. HSA-NUS Joint Scientific Symposium, May 19, 2004, Singapore.
  • Yang XX, Hu ZP, Chan SY, Goh BC & Zhou SF. Thalidomide alleviated the toxicity of irinotecan (CPT-11) in rats. The 5th Combined Annual Scientific Meeting in Singapore, 12-14 May, 2004, Singapore.
  • Zhou SF. Development of anticancer herbal medicines. The 6th Guangzhou Convention of Overseas Chinese Scholars in Science and technology, December 28-30, 2003, Guangzhou, Guangdong, China.
  • Zhou SF, Zhang JP, Guan YY, Wu JH, Xu AL & Huang M. Polymorphisms of the thiopurine S-methyltransferase gene in four racial groups of Chinese. The 4th Sino-Singapore Conference of Biotechnology, November 11-13, 2003, Singapore.
  • Yang XX, Chan SY, Goh BC & Zhou SF. Combination of irinotecan with thalidomide in the rat. The 4th Sino-Singapore Conference of Biotechnology, November 11-13, 2003, Singapore.
  • Paxton JW, Kestell P & Zhou SF. Combination of cyclophosphamide and thalidomide. Annual Meeting of Oncology, April 1-3, 2003, Auckland, New Zealand.
  • Zhou SF, Li Y, Kestell P & Paxton JW. Preliminary study on the transport of thalidomide by human intestinal Caco-2 cells. 11th North American ISSX meeting, October 27-31, 2002, Orlando, Florida.
  • Li Y, Zhou SF, Kestell P & Paxton JW. Transport of thalidomide by human intestinal Caco-2 cells.  Annual Meeting ofAustralian Medical Congress, November 2002, Melbourne, Victoria, Australia.
  • Paxton JW, Ding Q, Zhou SF& Kestell P. Pharmacokinetic interactions between cyclophosphamide and thalidomide. British Pharmacological Society (BPS) Annual Meeting 2002.
  • Paxton JW, Ding Q, Zhou SF& Kestell P. Mechanisms for the pharmacokinetic interactions between cyclophosphamide and thalidomide. Annual Meeting of Australian Medical Congress, November 2002, Melbourne, Victoria, Australia.
  • Gao YH & Zhou SF. Mechanisms for the antiulcer effect of Ganoderma lucidum polysaccharides. Annual Symposium on Ganoderma Science, 2002, Shanghai, China.
  • Zhou SF, Feng X, Kestell P, Wilson WR & Paxton JW. Preliminary studies on the transport of the anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by Caco-2 monolayers. Proceedings of Annual Meeting of Australasian Society of Clinical & Experimental Pharmacology & Toxicology (ASCEPT) 2001; 53.
  • Ding Q, Kestell P, Ching LM, Zhou SF& Paxton JW. Pharmacokinetic interactions between cyclophosphamide and thalidomide. Proceedings of Annual Meeting of Australasian Society of Clinical & Experimental Pharmacology & Toxicology (ASCEPT) 2001; 110.
  • Chiang D, Kestell P, Zhou SF& Paxton JW. Inhibition of CYP1A2-mediated reaction by acridine analogues in human liver microsomes. Proceedings of Annual Meeting of Australasian Society of Clinical & Experimental Pharmacology & Toxicology (ASCEPT) 2001; 111.
  • Zhou SF, Chin R, Kestell P, Baguley BC, Denny WA & Paxton JW. Metabolism of the anticancer agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA): inhibition by xanthenone analogues in human liver microsomes. Drug Metab Rev 2001; 33(Suppl 1): P168.
  • Gao YH & Zhou SF. Isolation and characterization of glycosaminoglycan from Ganoderma lucidum, a medicinal mushroom. Drug Metab Rev 2001; 33(Suppl 1): P75.
  • Zhou SF, Paxton JW, Tingle MD & Kestell P. Metabolic interaction between the novel anticancer agent, 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and thalidomide. Drug Metab Rev 2000; 32(Suppl 2): P292.
  • Paxton JW, Zhou SF, Kestell P & Tingle MD. Hydroxylation of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by human liver microsomes.  Drug Metab Rev 2000; 32(Suppl 1): P90.
  • Zhou SF, Paxton JW, Tingle MD & Kestell P. Identification of the human cytochrome P450 isoenzyme for the 6-methylhydroxylation of the novel antitumour agent 5,6-dimethylxanthenone-4-acetic acid in liver microsomes. Proceedings of Annual Meeting of Australasian Society of Clinical & Experimental Pharmacology & Toxicology (ASCEPT)/Br Pharmacological Society 2000; 7: P117.
  • Kestell P, Zhao LL, Ching LM, Baguley BC, Zhou SF& Paxton JW. Effects of thalidomide and cyproheptadine (CPD) on the metabolism and biliary excretion of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).Proceedings o AnnualMeeting of Australasian Society of Clinical & Experimental Pharmacology & Toxicology (ASCEPT)/Br Pharmacological Society 2000; 7: P56.
  • Zhou SF, Paxton JW, Tingle MD & Kestell P. Reactivity of the β-1-glucuronide of the novel antitumour agent 5,6-dimethyl-xanthenone-4-acetic acid (DMXAA).Proceedings of Annual Meeting of Australasian Society of Clinical & Experimental Pharmacology & Toxicology (ASCEPT, NZ section) 2000; P12.
  • Chin R, Zhou SF, Paxton JW, Tingle MD & Kestell P. Inhibition of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) metabolism in human liver microsomes by clinical anticancer agents and xanthenone analogues. Proceedings of Annual Meeting of Australasian Society of Clinical & Experimental Pharmacology & Toxicology (ASCEPT, NZ section) 2000; P10.
  • Gao YH, Chen GL, Lan J, Gao H & Zhou SF. Extraction of Ganoderma lucidum at relatively low temperature. Annual Symposium on Ganoderma lucidum Auckland, April 2002.
  • Zhou SF, Gao YH, Chen GL, Dai XH & Ye JX. A Phase I/II study of a Ganoderma lucidum extract in patients with advanced cancer. Annual Symposium on Ganoderma lucidum Auckland, April 2002.
  • Lan J, Gao YG, Hou JM, Ma AG, Gao H & Zhou SF. Isolation and characterization of glycosaminoglycan from Ganoderma. Annual Symposium on Ganoderma lucidum April 2002, Auckland, New Zealand.
  • Chen GL, Ye JX, Gao YH, Zhou SF& Dai XH. A multi-center, randomized, and double-blind study of Ganoderma lucidum in neurasthenia. Annual Symposium on Ganoderma lucidum April 2002, Auckland, New Zealand.
  • Dai XH, Chen GL, Gao YH, Zhou SF& Ye JX. A pilot study of a Ganoderma lucidum extract in patients with advanced lung cancer. Annual Symposium on Ganoderma lucidum April 2002, Auckland, New Zealand.
  • Zhou SF, Paxton JW, Tingle MD, Kestell P & Ching LM. Glucuronidation of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in mouse, rat and human liver microsomes. Proceedings of Australasian Society of Clinical & Experimental Pharmacology & Toxicology(ASCEPT) 1999: 6: P184.
  • Paxton JW, Zhou SF, Kestell P, Zhao LL, Ching LM, Tingle MD & Baguley BC. A species difference in the pharmacokinetic response by 5,6-dimethylxanthenone-4-acetic acid(DMXAA) tothalidomide. Proceedings of Australasian Society of Clinical & Experimental Pharmacology & Toxicology (ASCEPT) 1999; 6: P183.
  • Paxton JW, Zhou SF, Kestell P, Zhao LL, Ching LM, Tingle MD & Baguley BC. Binding of the 5,6-dimethylxanthenone-4-acetic acid (DMXAA) to plasma proteins and red blood cells in various species. Proceedings of Australasian Society of Clinical & Experimental Pharmacology & Toxicology (ASCEPT) 1999; 6: P148.
  • Zhou SF, Paxton JW, Tingle MD & Kestell P. The 6-methylhydroxylation of the experimental anticancer drug 5,6-dimethylxanthenone-4-acetic acid in human liver microsomes. Proceedings of Australasian Society of Clinical & Experimental Pharmacology & Toxicology (ASCEPT) 1999; 6: P139.
  • Zhou SF, Paxton JW, Tingle MD, Kestell P & Ching LM. Inhibition of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) metabolism in vitro in the rat. Proceedings of Australasian Society of Clinical & Experimental Pharmacology & Toxicology (ASCEPT, NZ Section) 1998; P9.
  • Kestell P, Paxton JW, Zhou SF& Baguley BC. Identification of major metabolites of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid in human urine. Proceedings of International Society of the Study of Xenobiotics (ISSX) 1998; 13: P207.
  • Zhou SF, Li YY & Wu HS. Management of relapsed peptic ulcers in Chinese. Annual Meeting of Guangdong Gastroenterology Society Shenzhen, Guangdong, China, 1995.
  • Zhou SF, Li YY & Wu HS. The role of Helicobacter pylori eradication in the prevention of peptic ulcer rebleeding. Annual Meeting of Guangdong Gastroenterology Society Guangzhou, Guangdong, China, October 1994.
  • Zhou SF& Li YY. Medical care pay systems in Guangzhou. Annual Meeting of China Hospital Administration Shanghai, China, December 1993.
  • Zhou SF& Li YY. A cost-effectiveness analysis in patients with chronic peptic ulcer diseases. Annual Meeting of Chinese Hospital Administer Association May 1993.
  • Zhou SF& Ou BX. The genotoxicity of sodium selenite in vitro and in vivo. International Conference on Safety and Application of Selenium Products Jinan, Shandong, China, October 1992.
  • Zhou SF& Li YY. The clinical features of peptic ulcers caused by hepatic diseases in Chinese patients. Chinese Hepatologist Association Annual Conference Harbin, Heilongjiang, China, June 1991.
  • Zhou SF& Li YY.A cost-effect analysis of patients with cirrhosis in a gastroenterology unit of China. National Conference onHospital Administration Beijing, China, September 1990.

 

 

 

Shufeng Zhou

Professor

 

  • : 813 9746276
    Fax:813 9059885

  • DEPARTMENT

    College of Pharmacy & Morsani College of Medicine
    University of South Florida (USF)

     

  • COUNTRY USA